Eritrogen Injection Pre-filled Synringe 4000 IU

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic

Therapeutic Area :

Chronic Kidney Diseases

Description:

Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Eritrogen (epoetin alfa) (Epoetin alfa), a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin.1 It has a molecular weight of 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin. Eritrogen (epoetin alfa) is formulated as a sterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution for intravenous (IV) or subcutaneous (SC) administration.

Eritrogen Injection Pre-filled Synringe 2000 IU

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic

Therapeutic Area :

Chronic Kidney Diseases

Description:

Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Eritrogen (epoetin alfa) (Epoetin alfa), a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin. It has a molecular weight of 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin. Eritrogen (epoetin alfa) is formulated as a sterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution for intravenous (IV) or subcutaneous (SC) administration.

Eritrogen Injection 10000 IU

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic

Therapeutic Area :

Chronic Kidney Diseases

Description:

Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Eritrogen (epoetin alfa) (Epoetin alfa), a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin.1 It has a molecular weight of 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin. Eritrogen (epoetin alfa) is formulated as a sterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution for intravenous (IV) or subcutaneous (SC) administration.

Eritrogen Injection 4000 IU

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic

Therapeutic Area :

Chronic Kidney Diseases

Description:

Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Eritrogen (epoetin alfa) (Epoetin alfa), a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin.1 It has a molecular weight of 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin. Eritrogen (epoetin alfa) is formulated as a sterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution for intravenous (IV) or subcutaneous (SC) administration.

Filgen Injection

All, All, Area, Cancer, Therapeutic, Vasopressin Analogue

Therapeutic Segment

Recombinant human granulocyte colony-stimulating factor (G-CSF)

Description

Filgen (filgrastim) is a 175 amino acid human granulocyte colony-stimulating factor (G-CSF) manufactured by recombinant DNA technology. Filgen is produced by Escherichia coli (E coli) bacteria into which has been inserted the human granulocyte colony-stimulating factor gene. Filgen has a molecular weight of 18‚800 daltons. The protein has an amino acid sequence that is identical to the natural sequence predicted from human DNA sequence analysis‚ except for the addition of an N-terminal methionine necessary for expression in E coli.

INF -A Injection

All, All, Area, Chronic Hepatitis C, Hairy Cell Leukemia, Recombinant Human Interferon, Therapeutic

Description:

INF-A (Interferon alfa-2a, recombinant) is a sterile protein product for use by injection. INF-A (interferon alfa-2a, recombinant) is manufactured by recombinant DNA technology that employs a genetically engineered Escherichia coli bacterium containing DNA that codes for the human protein. Interferon alfa-2a, recombinant is a highly purified protein containing 165 amino acids, and it has an approximate molecular weight of 19,000 daltons.

INF Injection

All, All, Area, Chronic Hepatitis B, Chronic Hepatitis C, Condylomata Acuminata, Hairy Cell Leukemia, Malignant Melanoma, Recombinant Human Interferon, Therapeutic

Description:

INF (Interferon alfa-2b) for intramuscular, subcutaneous, intralesional, or intravenous injection is a purified sterile recombinant interferon product. INF recombinant for Injection has been classified as an alpha interferon and is a water-soluble protein with a molecular weight of 19,271 daltons produced by recombinant DNA techniques. It is obtained from the bacterial fermentation of a strain of Escherichia coli bearing a genetically engineered plasmid containing an interferon alfa2b gene from human leukocytes.

Eritrogen Injection 2000 IU

All, All, Anemia, Area, Recombinant Human Erythropoietin, Therapeutic

Therapeutic Area :

Chronic Kidney Diseases

Description:

Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Eritrogen (epoetin alfa) (Epoetin alfa), a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin. It has a molecular weight of 30,400 daltons and is produced by mammalian cells into which the human erythropoietin gene has been introduced. The product contains the identical amino acid sequence of isolated natural erythropoietin. Eritrogen (epoetin alfa) is formulated as a sterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solution for intravenous (IV) or subcutaneous (SC) administration.

Peg- INF Injection

All, All, Area, Chronic Hepatitis B, Chronic Hepatitis C, Recombinant Human Interferon, Therapeutic

 

Therapeutic Area :

Hepapology

Description:

Peg-INF, peginterferon alfa-2a, is a covalent conjugate of recombinant alfa-2a interferon (approximate molecular weight [MW] 20,000 daltons) with a single branched bis-monomethoxy polyethylene glycol (PEG) chain (approximate MW 40,000 daltons). The PEG moiety is linked at a single site to the interferon alfa moiety via a stable amide bond to lysine. Peginterferon alfa-2a has an approximate molecular weight of 60,000 daltons. Interferon alfa-2a is produced using recombinant DNA technology in which a cloned human leukocyte interferon gene is inserted into and expressed in Escherichia coli.

1 … 3 4 5
Copyright © 2024 BF BIO. All rights reserved.

Designed & Developed by A2Z Creatorz